로딩 중…
지수 로딩 중…
Arbutus Biopharma Corporation
ABUS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.55+2.71%
2026-06-18
Price Chart
Arbutus Biopharma Corporation+31.12%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $899M |
| Revenue | $191M |
| Net Income | $161M |
| Total Assets | $277M |
| Net Assets | $260M |
| Value | |
| P/E | 5.59x |
| P/B | 3.45x |
| P/S | 4.69x |
| EV/EBITDA | 5.60x |
| FCF Yield | -3.82% |
| Profitability | |
| ROE | 61.77% |
| ROA | 57.99% |
| Op. Margin | 80.79% |
| Revenue Growth | 10054.54% |
| Financial Health | |
| Debt Ratio | 6.53% |
| Total Debt | $631000.00 |
| FCF | $-34M |
| Cash | $24M |
| Current Ratio | 54.26x |
| Net Debt/EBITDA | -0.15x |
| Performance | |
| 1Y Return | 31.12% |
| 1M Return | 8.33% |
| From 52W High | -10.78% |
| 1Y MDD | -25.86% |
| Trading | |
| Volume | 3,882,572 shares |
| Trading Value | $18M |
| Per Share | |
| EPS | $-0.16 |
| BPS | $0.40 |